Aug 14, 2020
Global $343M AI in Drug Discovery Market 2020: Expected to Grow at a CAGR of 43.24% Throughout 2020-2026
Aug 13, 2020
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
Aug 13, 2020
BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Clinical Trial Update
Aug 13, 2020
Lynda Tussey, PhD joins Vaxess Technologies as Chief Development Officer
Aug 12, 2020
Moleculin Biotech, Inc. Reports Financial Results for the Quarter Ended June 30, 2020
Aug 11, 2020
JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials
Jun 15, 2020
New Research Sheds Light on Intentional Non-adherence in Clinical Trials
Jun 15, 2020
Koneksa Joins the Critical Path Institute ePRO Consortium
Jun 12, 2020
BiondVax Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Jun 10, 2020
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
Jun 10, 2020
NIH Report on Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Concludes Both Primary Endpoints Achieved
Jun 08, 2020
Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients
Jun 02, 2020
Phlexglobal Providing Vital Support for COVID-19 Clinical Trials
Jun 02, 2020
MindMed's Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD
Jun 02, 2020
Global Fragment-based Drug Discovery Market 2020: Library and Service Providers
Jun 01, 2020
Lodo Therapeutics to Present at Jefferies Virtual Healthcare Conference
May 27, 2020
CNS Provides Update on Development Agreement for WP1122
May 27, 2020
RegeneRx Advisory on Reclassification of Thymosin Beta 4 from Drug to Biologic
May 27, 2020
COVID-19 Response Teaches Industry that Investing in Patient Partnership is Key to all Research Endeavors
May 26, 2020
Frontage Laboratories, Inc. establishes a QWBA Center of Excellence (COE) in Exton PA